- Home
- ATAT vs MIR Comparison
ATAT vs MIR Comparison
Compare ATAT & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAT
- MIR
- Stock Information
- Founded
- ATAT 2013
- MIR 2005
- Country
- ATAT China
- MIR United States
- Employees
- ATAT N/A
- MIR N/A
- Industry
- ATAT Hotels/Resorts
- MIR Industrial Machinery/Components
- Sector
- ATAT Consumer Discretionary
- MIR Technology
- Exchange
- ATAT Nasdaq
- MIR Nasdaq
- Market Cap
- ATAT 4.3B
- MIR 4.4B
- IPO Year
- ATAT 2022
- MIR N/A
- Fundamental
- Price
- ATAT $30.67
- MIR $19.65
- Analyst Decision
- ATAT Strong Buy
- MIR Strong Buy
- Analyst Count
- ATAT 2
- MIR 4
- Target Price
- ATAT $37.40
- MIR $18.75
- AVG Volume (30 Days)
- ATAT 1.6M
- MIR 3.6M
- Earning Date
- ATAT 05-22-2025
- MIR 07-31-2025
- Dividend Yield
- ATAT 4.21%
- MIR N/A
- EPS Growth
- ATAT 28.10
- MIR N/A
- EPS
- ATAT 1.25
- MIR N/A
- Revenue
- ATAT $1,059,112,934.00
- MIR $870,200,000.00
- Revenue This Year
- ATAT $30.64
- MIR $6.45
- Revenue Next Year
- ATAT $22.28
- MIR $7.51
- P/E Ratio
- ATAT $24.57
- MIR N/A
- Revenue Growth
- ATAT 43.38
- MIR 7.25
- 52 Week Low
- ATAT $15.22
- MIR $9.11
- 52 Week High
- ATAT $34.23
- MIR $20.80
- Technical
- Relative Strength Index (RSI)
- ATAT 51.23
- MIR 57.14
- Support Level
- ATAT $30.46
- MIR $19.73
- Resistance Level
- ATAT $33.40
- MIR $20.68
- Average True Range (ATR)
- ATAT 1.16
- MIR 0.62
- MACD
- ATAT -0.26
- MIR -0.16
- Stochastic Oscillator
- ATAT 23.96
- MIR 42.50
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.